BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Neurogene Appoints Industry Leaders Dr. Sukumar Nagendran and Dr. Serge Stankovic to Board of Directors

  Neurogene, Inc., a company founded with a mission to bring life-changing medicines to patients and families affected by rare neurological diseases, today announced the appointment of two biotech industry leaders to its board of directors: Dr. Sukumar Nagendran and Dr. Srdjan (Serge) Stankovic.

  February 27, 2019

   · 

  3 min read
• FDA

  US FDA Approves Expanded FARXIGA and XIGDUO XR Labels for Use in Patients with Type 2 Diabetes and Moderate Renal Impairment

  Updated label confirms the well-established efficacy and safety profile for FARXIGA and XIGDUO XR

  February 27, 2019

   · 

  12 min read
• Indivior Announces Launch of PERSERIS™ (risperidone) for the Treatment of Schizophrenia in Adults

  PERSERIS is the only subcutaneous risperidone-containing long-acting injectable available in the United States

  February 27, 2019

   · 

  9 min read
• BioMidwest

  As other states follow Minnesota’s lead to stabilize health insurance, new governor rejects program in his budget request

  Expenses for the state’s reinsurance program that helps pay high medical bills for people who buy their own insurance are about half the amount expected.

  February 27, 2019

   · 

  4 min read
• Job Trends

  Heska to Present at Upcoming Conferences in March 2019

  Heska Corporation (NASDAQ: HSKA - News; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska’s President & Chief Executive Officer will be presenting at the following upcoming conferences in March 2019

  February 27, 2019

   · 

  1 min read
• Business

  ANI Pharmaceuticals Reports Record Full Year and Fourth Quarter 2018 Results and Provides 2019 Guidance

  Record net revenues of $201.6 million, an increase of 14% versus 2017

  February 27, 2019

   · 

  28 min read
• FDA

  eNeura, Inc. Receives FDA Clearance for Acute Treatment and Prevention of Migraine in Children 12 Years of Age and Older

  eNeura’s sTMS is the only product available to patients 12 and older for both acute treatment of migraine and migraine prevention

  February 27, 2019

   · 

  3 min read
• Policy

  Oklahoma Mesothelioma Victims Center Now Urges a US Navy Veteran with Mesothelioma or Asbestos Lung Cancer in Oklahoma to Call Them for Direct Access to Famed Attorney Erik Karst for an Honest Conversation About Compensation - Skill Matters

  We are urging a US Navy Veteran in Oklahoma who has just been diagnosed with mesothelioma or asbestos exposure lung cancer and or their loved ones to call us anytime at 800-714-0303 for almost instant access to famed mesothelioma attorney Erik Karst founding partner of Karst von Oiste.

  February 27, 2019

   · 

  3 min read
• Business

  vTv Therapeutics Announces 2018 Fourth Quarter and Full Year Financial Results and Update

  Licensing partners also continue to advance GLP-1R agonist, PPAR-delta, and PDE4 programs

  February 27, 2019

   · 

  12 min read
• Biotech Beach

  From FDA Recall to Rebirth: Liveyon Ready to Reinvent Regenerative Medicine

  Behind-the-Scenes Look at Events Surrounding FDA Recall of Genetech Products and Plans for Liveyon to Produce its Own Stem Cell Concentrate Derived from Umbilical Cord Blood

  February 27, 2019

   · 

  4 min read